Verona Pharma

Verona Pharma: Ownership & structure

Merck & Co. holds 75–100% of Verona Pharma.

Data updated Nov 21, 2026 · Back to the company report

Owners & entities

Merck & Co. holds 75–100% of Verona Pharma.

Holders
ownership of shares 75 to 100 percent; voting rights 75 to 100 percent; right to appoint and remove directors · find-and-update.company-information.service.gov.uk ↗
75–100%
Legal entities1 in 1 country
operator · GB CRN 05375156
GB
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors5
venBio PartnersVia a fund
43 portfolio companies: Sanofi, Insamo, Axent Biosciences and 40 more
Aisling CapitalVia a fund
117 portfolio companies: CoolSculpting, Zosanopharma, Shofsky and 114 more
129 portfolio companies: IMIO, Alethio Therapeutics, Reyva and 126 more
131 portfolio companies: Veracyte, UpDoc, Zura Bio and 128 more
NEAVia a fund
672 portfolio companies
Show all 5